Desmoplastic small round cell tumour

1 trials 1 recruiting MedDRA PT
1 Registered trials
1 Recruiting
1 Unique sponsors
2 Unique IMPs
0 Commercial trials
Drug classes (ATC)
L Oncology (ATC L) 1
Mechanism of action (INN-stem analysis)
Topoisomerase I inhibitor 1 substance
Unknown / small molecule 1 substance
Phase II: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase II

1 trial
  • Italian Sarcoma Group Academic
    IRINOTECAN HYDROCHLORIDE TRIHYDRATE; LURBINECTEDIN
    2024-519261-21-00 2 countries 2025 n=20
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Italian Sarcoma Group Academic 1 Phase II 1
New trials by year
2025
1
← All indication landscapes